News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
765,659 Results
Type
Article (51416)
Company Profile (296)
Press Release (713931)
Multimedia
Podcasts (106)
Webinars (20)
Section
Business (212954)
Career Advice (2121)
Deals (36683)
Drug Delivery (135)
Drug Development (84094)
Employer Resources (174)
FDA (17303)
Job Trends (15832)
News (360904)
Policy (34932)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2821)
Accelerated approval (43)
Adcomms (30)
Allergies (170)
Alliances (51763)
ALS (201)
Alzheimer's disease (1822)
Antibody-drug conjugate (ADC) (402)
Approvals (17636)
Artificial intelligence (645)
Autoimmune disease (243)
Automation (52)
Bankruptcy (375)
Best Places to Work (12096)
BIOSECURE Act (20)
Biosimilars (209)
Biotechnology (190)
Bladder cancer (181)
Brain cancer (69)
Breast cancer (714)
Cancer (5556)
Cardiovascular disease (474)
Career advice (1806)
Career pathing (44)
CAR-T (310)
CDC (61)
Celiac Disease (2)
Cell therapy (824)
Cervical cancer (45)
Clinical research (72373)
Collaboration (2029)
Company closure (4)
Compensation (1310)
Complete response letters (77)
COVID-19 (2861)
CRISPR (102)
C-suite (1062)
Cystic fibrosis (150)
Data (7289)
Decentralized trials (3)
Denatured (38)
Depression (165)
Dermatology (70)
Diabetes (567)
Diagnostics (7081)
Digital health (55)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (305)
Drug pricing (206)
Drug shortages (34)
Duchenne muscular dystrophy (271)
Earnings (93360)
Editorial (66)
Employer branding (21)
Employer resources (153)
Events (123772)
Executive appointments (1076)
FDA (20899)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1692)
Gene editing (220)
Generative AI (62)
Gene therapy (672)
GLP-1 (1094)
Government (4997)
Grass and pollen (6)
Guidances (402)
Healthcare (20047)
HIV (78)
Huntington's disease (53)
IgA nephropathy (93)
Immunology and inflammation (284)
Immuno-oncology (88)
Indications (164)
Infectious disease (3196)
Inflammatory bowel disease (210)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (279)
Interviews (324)
IPO (17021)
IRA (51)
Job creations (4061)
Job search strategy (1509)
JPM (58)
Kidney cancer (18)
Labor market (94)
Layoffs (577)
Leadership (37)
Legal (8510)
Liver cancer (102)
Longevity (30)
Lung cancer (747)
Lymphoma (414)
Machine learning (55)
Management (59)
Manufacturing (975)
MASH (185)
Medical device (14912)
Medtech (14999)
Mergers & acquisitions (20854)
Metabolic disorders (1487)
mRNA (190)
Multiple sclerosis (178)
NASH (17)
Neurodegenerative disease (405)
Neuropsychiatric disorders (103)
Neuroscience (3289)
Neurotech (1)
NextGen: Class of 2026 (6922)
Non-profit (4786)
Now hiring (74)
Obesity (708)
Opinion (298)
Ovarian cancer (199)
Pain (242)
Pancreatic cancer (271)
Parkinson's disease (358)
Partnered (34)
Patents (568)
Patient recruitment (634)
Peanut (62)
People (62274)
Pharmaceutical (65)
Pharmacy benefit managers (33)
Phase 1 (22527)
Phase 2 (31789)
Phase 3 (23731)
Pipeline (7515)
Policy (317)
Postmarket research (2744)
Preclinical (9591)
Press Release (67)
Prostate cancer (286)
Psychedelics (52)
Radiopharmaceuticals (322)
Rare diseases (1033)
Real estate (6360)
Recruiting (70)
Regulatory (26585)
Reports (54)
Research institute (2575)
Resumes & cover letters (363)
Rett syndrome (33)
RNA editing (18)
RSV (90)
Schizophrenia (175)
Series A (277)
Series B (210)
Service/supplier (12)
Sickle cell disease (109)
Special edition (22)
Spinal muscular atrophy (169)
Sponsored (47)
Startups (3883)
State (2)
Stomach cancer (19)
Supply chain (131)
Tariffs (90)
The Weekly (66)
Vaccines (1117)
Venture capital (102)
Weight loss (469)
Women's health (118)
Worklife (20)
Date
Today (138)
Last 7 days (592)
Last 30 days (2649)
Last 365 days (30780)
2026 (9193)
2025 (30909)
2024 (36103)
2023 (41145)
2022 (52383)
2021 (57101)
2020 (55911)
2019 (48795)
2018 (36938)
2017 (33746)
2016 (33564)
2015 (39609)
2014 (33324)
2013 (28558)
2012 (30846)
2011 (31551)
2010 (29924)
Location
Africa (816)
Alabama (93)
Alaska (7)
Arizona (343)
Arkansas (16)
Asia (42754)
Australia (7049)
California (12579)
Canada (3599)
China (1309)
Colorado (551)
Connecticut (558)
Delaware (382)
Europe (93156)
Florida (1898)
Georgia (411)
Hawaii (3)
Idaho (66)
Illinois (1049)
India (85)
Indiana (582)
Iowa (22)
Japan (513)
Kansas (132)
Kentucky (48)
Louisiana (39)
Maine (75)
Maryland (1550)
Massachusetts (9069)
Michigan (360)
Minnesota (713)
Mississippi (7)
Missouri (145)
Montana (33)
Nebraska (29)
Nevada (142)
New Hampshire (89)
New Jersey (3378)
New Mexico (30)
New York (3336)
North Carolina (1672)
North Dakota (8)
Northern California (6228)
Ohio (376)
Oklahoma (24)
Oregon (42)
Pennsylvania (2543)
Puerto Rico (28)
Rhode Island (52)
South America (1201)
South Carolina (84)
South Dakota (2)
Southern California (4947)
Tennessee (205)
Texas (2013)
United States (45014)
Utah (379)
Vermont (1)
Virginia (301)
Washington D.C. (83)
Washington State (1040)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
765,659 Results for "corvia medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Corvia Medical closes $55 million funding round to complete confirmatory trial and pursue FDA approval of Corvia Atrial Shunt
June 17, 2025
·
2 min read
Genetown
Newly Published Data in JAMA Cardiology Demonstrates Favorable Long-term Effects of the Corvia Atrial Shunt in Heart Failure Patients
Corvia Medical, Inc announced the publication in JAMA Cardiology of two-year echocardiographic data from its REDUCE LAP-HF II randomized clinical trial of the Corvia® Atrial Shunt, offering groundbreaking insight into the impact of a shunt on the heart.
May 7, 2024
·
2 min read
News
Corvia Medical Announces Three-Year Clinical Trial Results Confirming Significant and Durable Benefits of the Corvia Atrial Shunt in Heart Failure Patients
October 25, 2024
·
3 min read
Press Releases
Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards
December 23, 2024
·
2 min read
Press Releases
PreveCeutical Medical Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director
March 30, 2026
·
7 min read
Press Releases
Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026
April 6, 2026
·
1 min read
Press Releases
Avanos Medical, Inc. to Present at the 2026 Citizens Life Sciences Conference
March 3, 2026
·
1 min read
Drug Development
Corvia Medical Releases Two-year Clinical Trial Results Confirming Sustained Benefit and Safety of Its Atrial Shunt in Heart Failure Patients
Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, announced two-year results from its REDUCE LAP-HF II randomized clinical trial confirming safety and sustained efficacy of the Corvia® Atrial Shunt in properly selected heart failure patients with preserved or mildly reduced ejection fraction.
May 22, 2023
·
3 min read
Genetown
CORVIA MEDICAL ANNOUNCES RANDOMIZATION OF FIRST PATIENT IN THE RESPONDER-HF CONFIRMATORY TRIAL
Corvia Medical, Inc., a company dedicated to transforming the treatment of heart failure (HF), announced the first patient has been randomized in RESPONDER-HF, a global confirmatory trial of the Corvia Atrial Shunt in heart failure patients with preserved (HFpEF) or mildly reduced (HFmrEF) ejection fraction.
December 6, 2022
·
4 min read
Press Releases
Medical Care Technologies Inc. (OTC PINK:MDCE) Reports 63% Revenue Growth, Strong Profitability, and Significant Cash Flow Improvement in 2025
March 26, 2026
·
3 min read
1 of 76,566
Next
